FDA Clearance Tracker · K252638
VeraPro S100 Multi-Use Syringe (018808); VeraPro S100 LV1 Low Viscosity Single-Use Syringe (018811); VeraPro AMT Auto-Manifold and Transducer (018814); VeraPro AngioTouch FLX165 Hand Controller Kit (018806); VeraPro AngioTouch HiFi165 Hand Controller Kit (018804)
Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 13, 2026
Substantially Equivalent
Time to decision
266 days
Received Aug 20, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K252638
- Device name
- VeraPro S100 Multi-Use Syringe (018808); VeraPro S100 LV1 Low Viscosity Single-Use Syringe (018811); VeraPro AMT Auto-Manifold and Transducer (018814); VeraPro AngioTouch FLX165 Hand Controller Kit (018806); VeraPro AngioTouch HiFi165 Hand Controller Kit (018804)
- Applicant
- Acist Medical Systems, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Aug 20, 2025
- Decided
- May 13, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Injector And Syringe, Angiographic (DXT)
- Device class
- Class II
- Regulation
- 21 CFR 870.1650
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DXT. The earliest in FDA's data is K781334, decided Aug 17, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252638
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Acist Medical Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VueJect® Ultrasound Enhancing Agent Delivery SystemThird-party review510(k)
K262115 · Decided Aug 3, 2026 · 41 days after receipt
Device type: Injector, Contrast Medium, Automatic (IZQ) · Cardiology
K252653 · Decided May 13, 2026 · 264 days after receipt
Device type: Injector And Syringe, Angiographic (DXT) · Cardiology
K233904 · Decided Jul 17, 2024 · 219 days after receipt
Device type: Transducer, Pressure, Catheter Tip (DXO) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.